Investor Relations
OTCHealth Inc.
Investor Relations
Building the Future of Accessible Hearing Care
OTCHealth Inc. is a multi-generational hearing health company with over 80 years of experience developing and bringing to market affordable, effective hearing solutions. Through our flagship brands - HearingAssist and iHEAR - we have helped more than 500,000 people across America hear better without the prohibitive cost of traditional clinical hearing care.
With a proven track record of distribution at the nation's largest retailers, established brand recognition, and a clear direct-to-consumer growth strategy, OTCHealth Inc. is positioned to capitalize on one of the most significant regulatory and demographic tailwinds in recent consumer health history: the FDA's 2022 deregulation of the over-the-counter hearing aid market.
A $9 Billion+ Market - Newly Opened to Innovation
In October 2022, the U.S. Food and Drug Administration enacted historic rules allowing adults with mild-to-moderate hearing loss to purchase hearing aids directly without a prescription or audiologist visit. This single regulatory change transformed a tightly gatekept clinical market into a massive direct-to-consumer opportunity.
80M+ Americans Affected
More than 80 million Americans experience some degree of hearing loss - yet fewer than 20% currently use any hearing device. The unmet need is enormous and growing as the U.S. population ages.
$9B+ OTC Market by 2030
Industry analysts project the U.S. OTC hearing aid and PSAP market to exceed $9 billion. FDA deregulation has accelerated the shift from clinical to consumer channels, directly benefiting established OTC brands.
Traditional Barriers Removed
Clinical hearing aids have historically cost $3,000-$8,000 per pair, requiring doctor visits and prescriptions. The OTC pathway eliminates these barriers, opening the market to price-sensitive consumers seeking accessible alternatives.
First-Mover Advantage
OTCHealth Inc. brands were in the market long before deregulation, establishing consumer trust, retail shelf space, and distribution infrastructure that new entrants must now try to replicate from scratch.
Two Trusted Brands. One Clear Mission.
OTCHealth Inc. owns and operates two established hearing health brands, each targeting complementary segments of the growing OTC market.
HearingAssist is one of the most recognized OTC hearing health brands in the United States, built over decades of retail distribution at major national chains. Known for value, reliability, and accessibility, HearingAssist has served hundreds of thousands of Americans seeking affordable hearing support.
Previously available at Walmart, CVS, Target, Walgreens, Rite Aid, Best Buy, and Amazon, the brand carries unmatched retail credibility in the OTC hearing category.
iHEAR represents OTCHealth's next-generation product line, combining advanced sound technology with consumer-friendly design. The iHEAR lineup is the spearhead of our direct-to-consumer strategy through OTCHealthMart.com.
A Growing Portfolio of Solutions
OTCHealth Inc. maintains an active product development pipeline, expanding across price points and technology tiers to serve a broad spectrum of consumer needs.
| Product | Category | Price Point | Status |
|---|---|---|---|
| iHEAR TReO | PSAP / Entry-Level | $99 / $149 | Available Now |
| iHEAR Matrix | Advanced OTC | TBD | Pre-Sale June 2026 |
| iHEAR Axis | Premium OTC | TBD | In Development |
| iHEAR Linx | Premium OTC | TBD | In Development |
Why OTCHealth Inc. Stands Apart
Our competitive position is built on decades of operational experience, brand trust, and retail relationships that cannot be replicated quickly by new market entrants.
-
80+ Years of Industry Heritage - Three generations of family leadership have built institutional knowledge, supplier relationships, and consumer trust that span decades.
-
500,000+ Satisfied Customers - A large, loyal customer base provides social proof, repeat purchase opportunity, and a foundation for referral-driven growth.
-
Proven National Retail Distribution - Products previously distributed through Walmart, CVS, Target, Walgreens, Rite Aid, Best Buy, and Amazon - a retail footprint that establishes deep credibility with future trade and DTC partners.
-
Two Established Brand Assets - HearingAssist and iHEAR address different consumer segments and price points, allowing OTCHealth to serve a broad market without brand overlap.
-
Strategic Direct-to-Consumer Pivot - Our shift to OTCHealthMart.com captures higher margins, richer customer data, and eliminates retailer dependency - positioning the company for scalable growth in a digital-first consumer environment.
-
Regulatory Tailwind - The 2022 FDA OTC hearing aid ruling opens our target market to tens of millions of new consumers, directly accelerating adoption of the products and brands we have already built.
Distributed Across America's Largest Retailers
OTCHealth Inc. has an established history of national retail distribution through the most trusted consumer health and electronics chains in the United States - a foundation of credibility that underpins our brand recognition and future growth strategy.
Current Focus & Growth Strategy
OTCHealth Inc. is executing a deliberate pivot from traditional retail distribution to a high-margin, data-driven direct-to-consumer model centered on OTCHealthMart.com. This strategy enables us to own the customer relationship end-to-end - from awareness through repurchase - while capturing significantly improved unit economics compared to retail channel sales.
Direct-to-Consumer Platform
OTCHealthMart.com serves as the primary sales and customer engagement platform, enabling direct marketing, subscription models, and customer lifetime value optimization.
Product Line Expansion
The iHEAR Matrix pre-sale in June 2026 marks the beginning of a systematic portfolio expansion into higher-technology, higher-margin product tiers across the OTC hearing category.
Brand Awareness Campaigns
Leveraging 80+ years of heritage and 500K+ customers served, we are building targeted digital and content marketing programs to drive qualified traffic and accelerate new customer acquisition.
Selective Retail Re-Entry
As the DTC platform matures, OTCHealth evaluates strategic retail partnerships that complement - rather than replace - the direct channel, optimizing reach without margin compression.
Experienced, Mission-Driven Leadership
OTCHealth Inc. is led by experienced operators who have grown up in the hearing health industry and are deeply committed to the company's mission of making quality hearing care accessible to all Americans.
Matthew Moore is a third-generation hearing health industry executive, bringing the accumulated knowledge, supplier relationships, and consumer insight of more than 80 years of family heritage to OTCHealth Inc. As President and Co-Founder, Matthew leads the company's strategic direction, brand development, and growth initiatives. His deep roots in the category position OTCHealth uniquely as both a heritage brand and an agile direct-to-consumer innovator in the rapidly evolving OTC hearing market.
Investor Inquiries
OTCHealth Inc. welcomes inquiries from qualified investors, institutions, and strategic partners interested in the OTC hearing health opportunity.
Contact Investor RelationsCare@OTCHealthMart.com
Forward-Looking Statements Disclaimer
This page contains forward-looking statements within the meaning of applicable securities laws, including statements regarding market opportunity, product development timelines, distribution strategies, growth plans, and financial expectations. These statements are based on management's current beliefs, assumptions, and expectations and are subject to significant risks and uncertainties. Actual results may differ materially from those expressed or implied by forward-looking statements due to factors including, but not limited to: market competition, regulatory changes, changes in consumer demand, product development delays, supply chain disruptions, and general economic conditions. OTCHealth Inc. undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future events, or otherwise. Nothing on this page constitutes an offer to sell or solicitation of an offer to buy any securities. Prospective investors should conduct their own due diligence and consult with their financial, legal, and tax advisors before making any investment decision.